ANIXA BIOSCIENCES, INC. (ANIX) Overview
- 1 May 2026: Period ending 31 Jul 2026; Estimate (m); Actual -0.08; Beat / miss (m).
- 1 Feb 2026: Period ending 30 Apr 2026; Estimate (m); Actual -0.07; Beat / miss (m).
- 1 Nov 2025: Period ending 31 Jan 2026; Estimate (m); Actual -0.08; Beat / miss (m).
- 1 May 2025: Period ending 31 Jul 2025; Estimate (m); Actual -0.07; Beat / miss (m).
Stock Price Chart
View more →Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
- Last close
- $3.18
- Previous close
- $2.85
- Change
- $0.33
- Change (%)
- 11.58%
- Close date
- 2026-11-06
- Previous close date
- 2026-09-29
- Open
- (m)
- Day high
- (m)
- Day low
- (m)
- Last session volume
- (m)
- Last session value
- (m)
- Currency
- USD
- Price basis
- split-adjusted
- Volume basis
- (m)
Performance
View more →Cumulative total returns · 2026-09-29
YTD
- ANIX
- -8.65%
- S&P 500
- (m)
1 year
- ANIX
- -16.42%
- S&P 500
- (m)
3 years
- ANIX
- -12.84%
- S&P 500
- (m)
5 years
- ANIX
- -40.00%
- S&P 500
- (m)
Earnings trends
View more →Earnings per share
USD / share · As filed
31 Jul 2026 ○ Estimate (m) ● Actual -0.08
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 May 2026 | 31 Jul 2026 | (m) | -0.08 | (m) | (m) |
| 1 Feb 2026 | 30 Apr 2026 | (m) | -0.07 | (m) | (m) |
| 1 Nov 2025 | 31 Jan 2026 | (m) | -0.08 | (m) | (m) |
| 1 May 2025 | 31 Jul 2025 | (m) | -0.07 | (m) | (m) |
| 1 Feb 2025 | 30 Apr 2025 | (m) | -0.09 | (m) | (m) |
31 Oct 2025 ○ Estimate (m) ● Actual -0.34
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 Nov 2024 | 31 Oct 2025 | (m) | -0.34 | (m) | (m) |
| 1 Nov 2023 | 31 Oct 2024 | (m) | -0.39 | (m) | (m) |
| 1 Nov 2022 | 31 Oct 2023 | (m) | -0.32 | (m) | (m) |
| 1 Nov 2021 | 31 Oct 2022 | (m) | 0.45 | (m) | (m) |
(m)
Revenue vs. Earnings
USD
30 Apr 2023 ■ Revenue 0.21M ■ Earnings -2.29M — Profit margin -1089.52%
31 Oct 2024 ■ Revenue 0.21M ■ Earnings -12.55M — Profit margin -5978.10%
Analyst insights
View more →| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $3.18 | (m) | (m) | (m) | (m) |
Recent news
View more →(m)
YouTube videos mentioning ANIX
View more →(m)
Statistics
View more →Retained observations as of 2026-11-12; financial period ending 31 Oct 2024.
- Forward P/E
- (m)
- PEG ratio · 5-year expected
- (m)
- Shares held by insiders
- (m)
- Insider transactions · change (%)
- (m)
- Shares held by institutions
- (m)
- Institutional transactions · change (%)
- (m)
- Diluted EPS · 12 month
- (m)
- EPS estimate · next quarter
- (m)
- EPS estimate · next year
- (m)
- EPS growth · current annual estimate
- (m)
- EPS growth · next annual estimate
- (m)
- EPS growth · next 5 years expected
- (m)
- EPS growth · past 3 years annualized
- (m)
- EPS growth · past 5 years annualized
- (m)
- EPS change · 12 months vs prior year
- (m)
- EPS change · latest quarter vs previous quarter
- (m)
- Latest earnings report date
- (m)
- EPS surprise · latest reported quarter
- (m)
- Net income · 12 month
- $-12.55M
- Operating margin · 12 months
- -6586.19%
- Profit margin
- -5978.10%
- Return on assets · 12 month
- -53.29%
- Named executive and board stock awards · latest fiscal year
- (m)
- Index membership
- (m)
- Employees
- (m)
- IPO date
- (m)
- Options available
- (m)
- Shortable
- (m)
- Analyst recommendation
- (m)
- Analyst target price
- (m)
- Price volatility · week
- (m)
- Price volatility · month
- (m)
- Average true range · 14 sessions
- (m)
- Relative strength index · 14 sessions
- (m)
- Relative volume
- (m)
- Average daily volume
- 375.90K
- Latest session volume
- (m)
- Last session value
- (m)
- 30 days ago session value
- (m)
- 1 year ago session value
- (m)
- Number of trades
- (m)
- Total return · week
- 2.15%*
- Total return · month
- -18.10%*
- Total return · quarter
- 0.00%*
- Total return · half year
- 11.76%*
- Total return · year to date
- -8.65%*
- Total return · 1 year
- -16.42%*
- Total return · 3 years
- -12.84%*
- Total return · 5 years
- -40.00%*
- Market cap
- (m)
- Book value per share · latest quarter
- (m)
- Price / cash · latest quarter
- (m)
- Enterprise value
- (m)
- Enterprise value / revenue
- (m)
- Enterprise value / EBITDA
- (m)
- Dividend · 12 months per share
- (m)
- Dividend ex-date
- (m)
- Next dividend ex-date
- (m)
- Next dividend amount per share
- (m)
- Dividend growth · 3 years annualized
- (m)
- Dividend growth · 5 years annualized
- (m)
- R&D / revenue · 12 months
- 3045.71%
- Revenue · 12 month
- $210.00K
- Revenue growth · past 3 years annualized
- (m)
- Revenue growth · past 5 years annualized
- (m)
- Revenue change · 12 months vs prior year
- (m)
- Revenue change · latest quarter vs previous quarter
- (m)
- Revenue surprise · latest reported quarter
- (m)
- Levered free cash flow · 12 month
- (m)
- Debt / equity · latest quarter
- (m)
- Long-term debt / equity · latest quarter
- (m)
- Payables · latest quarter (USD)
- $525.00K
- Return on equity · 12 month
- (m)
- Return on invested capital · 12 months
- (m)
- Previous close
- (m)
- Latest closing price
- (m)
- Latest session change (%)
- (m)
- 52-week high
- (m)
- 52-week low
- (m)
- Price vs 20-session moving average
- (m)
- Price vs 50-session moving average
- (m)
- Price vs 200-session moving average
- (m)
- Float shares
- (m)
- Short float (%)
- (m)
- Short ratio (days to cover)
- (m)
- Short interest (shares)
- (m)
Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.
Holders breakdown
View more →| Breakdown | Ownership |
|---|---|
| (m) | Shares held by all insiders |
| (m) | Shares held by institutions |
| (m) | Float held by institutions |
| (m) | Institutions holding shares |
Other holders
(m)
Insider holders
(m)
Top institutional holders
(m)
Top mutual fund holders
(m)
ANIXA BIOSCIENCES, INC. Overview
View more →(m)
(m)
- SEC CIK
- 715446
- Industry (SIC)
- 2834 Pharmaceutical Preparations
- Country of operation
- United States
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, California, 95118, United States
- Fiscal year end
- 1031
- Phone
- 408-708-9808
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |